Characteristics and outcomes of children ≤ 10 kg receiving continuous kidney replacement therapy: a WE-ROCK study
Shina Menon,Michelle C Starr,Huaiyu Zang,Michaela Collins,Mihaela A Damian,Dana Fuhrman,Kelli Krallman,Danielle E Soranno,Tennille N Webb,Cara Slagle,Catherine Joseph,Susan D Martin,Tahagod Mohamed,Morgan E Beebe,Zaccaria Ricci,Nicholas Ollberding,David Selewski,Katja M Gist,WE-ROCK investigators,Emily Ahern,Ayse Akcan Arikan,Issa Alhamoud,Rashid Alobaidi,Pilar Anton-Martin,Shanthi S Balani,Matthew Barhight,Abby Basalely,Amee M Bigelow,Gabriella Bottari,Andrea Cappoli,Eileen A Ciccia,Denise Colosimo,Gerard Cortina,Sara De la Mata Navazo,Gabrielle DeAbreu,Akash Deep,Kathy L Ding,Kristin J Dolan,Sarah NFernandez Lafever,Ben Gelbart,Stephen M Gorga,Francesco Guzzi,Isabella Guzzo,Taiki Haga,Elizabeth Harvey,Denise C Hasson,Taylor Hill-Horowitz,Haleigh Inthavong,Ahmad Kaddourah,Aadil Kakajiwala,Aaron D Kessel,Sarah Korn,David M Kwiatkowski,Jasmine Lee,Laurance Lequier,Tina Madani Kia,Kenneth E Mah,Eleonora Marinari,Catherine Morgan,Theresa A Mottes,Melissa A Muff-Luett,Siva Namachivayam,Tara M Neumayr,Jennifer Nhan,Abigail O'Rourke,Matthew G Pinto,Dua Qutob,Valeria Raggi,Stephanie Reynaud,Zachary A Rumlow,María JSantiago Lozano,Emily See,Carmela Serpe,Alyssa Serratore,Ananya Shah,Weiwen V Shih,HStella Shin,Sonia Solomon,Rachana Srivastava,Natalja L Stanski,Erin K Stenson,Amy E Strong,Susan A Taylor,Sameer V Thadani,Amanda M Uber,Brynna Van Wyk,Emily E Zangla,Michael Zappitelli,T Christine E Alvarez,Elizabeth Bixler,Erica Blender Brown,Cheryl L Brown,Ambra Burrell,Anwesh Dash,Jennifer L Ehrlich,Simrandeep Farma,Kim Gahring,Barbara Gales,Madison R Hilgenkamp,Sonal Jain,Kate Kanwar,Jennifer Lusk,Christopher J Meyer,Katherine Plomaritas,Joshua Porter,Jessica Potts,Elizabeth Schneider,Vidushi Sinha,P J Strack,Sue Taylor,Katherine Twombley,Samantha Wallace,Janet Wang,Megan Woods,Marcia Zinger,Alison Zong
DOI: https://doi.org/10.1007/s00467-024-06438-x
2024-08-20
Abstract:Background: Continuous kidney replacement therapy (CKRT) is often used for acute kidney injury (AKI) or fluid overload (FO) in children ≤ 10 kg. Intensive care unit (ICU) mortality in children ≤ 10 kg reported by the prospective pediatric CRRT (ppCRRT, 2001-2003) registry was 57%. We aimed to evaluate characteristics associated with ICU mortality using a contemporary registry. Methods: The Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK) registry is a retrospective, multinational, observational study of children and young adults aged 0-25 years receiving CKRT (2015-2021) for AKI or FO. This analysis included patients ≤ 10 kg at hospital admission. Primary and secondary outcomes: ICU mortality and major adverse kidney events at 90 days (MAKE-90) defined as death, persistent kidney dysfunction, or dialysis within 90 days, respectively. Results: A total of 210 patients were included (median age 0.53 years (IQR, 0.1, 0.9)). ICU mortality was 46.5%. MAKE-90 occurred in 150/207 (72%). CKRT was initiated at a median 3 days (IQR 1, 9) after ICU admission and lasted a median 6 days (IQR 3, 16). On multivariable analysis, pediatric logistic organ dysfunction score (PELOD-2) at CKRT initiation was associated with increased odds of ICU mortality (aOR 2.64, 95% CI 1.68-4.16), and increased odds of MAKE-90 (aOR 2.2, 95% CI 1.31-3.69). Absence of comorbidity was associated with lower MAKE-90 (aOR 0.29, 95%CI 0.13-0.65). Conclusions: We report on a contemporary cohort of children ≤ 10 kg treated with CKRT for acute kidney injury and/or fluid overload. ICU mortality is decreased compared to ppCRRT. The extended risk of death and morbidity at 90 days highlights the importance of close follow-up.